[
  {
    "ts": null,
    "headline": "Income Strategy: 2 Terrific Blue Chips Yielding 5-7%",
    "summary": "Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has a 5.7% yield with reliable cash flows. Read more here.",
    "url": "https://finnhub.io/api/news?id=cea0e4bd9068b45446c4d1cc477aa537745441b00dc923693fe9272e6b5a7321",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742025600,
      "headline": "Income Strategy: 2 Terrific Blue Chips Yielding 5-7%",
      "id": 133178044,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/956437954/image_956437954.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has a 5.7% yield with reliable cash flows. Read more here.",
      "url": "https://finnhub.io/api/news?id=cea0e4bd9068b45446c4d1cc477aa537745441b00dc923693fe9272e6b5a7321"
    }
  }
]